SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4Konstantinos Tzelepis(The Gurdon Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute)Nature CommunicationsDecember 13, 201810.1038/s41467-018-07620-0Cited by 88SaveCiteExport RISWatch citationsRelated PapersGenome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis|Nature Genetics|2022|347